Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition

Targeting Tau N368 through immunotherapy alleviates tau-driven neurodegeneration, restores synaptic function, and improves accompanying Aβ pathology in AD models. Our results confirmed that Tau N368 is an exceptional biomarker and a promising therapeutic target, disrupting AD progression by addressing tau aggregation and its downstream effects.

Authors

Institutions

Publication Details

Journal
Molecular Neurodegeneration
Published
2025-05-27
DOI
https://doi.org/10.1186/s13024-025-00854-9
Citations
1
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
1.16

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition

Jie Xiang, Xi Ye, Xia Liu, Keqiang Ye et al.
1 citations
Molecular Neurodegeneration
Alzheimer's disease research and treatments
1.16
article

Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition

Jie Xiang, Xi Ye, Xia Liu, Keqiang Ye, Zhengjiang Qian, Zhentao Zhang, Zhi-Hao Wang, Shengxi Wu, Guangxing Wang, Ying Rao Wei
article en
1 citations

Abstract

Targeting Tau N368 through immunotherapy alleviates tau-driven neurodegeneration, restores synaptic function, and improves accompanying Aβ pathology in AD models. Our results confirmed that Tau N368 is an exceptional biomarker and a promising therapeutic target, disrupting AD progression by addressing tau aggregation and its downstream effects.

Molecular NeurodegenerationVol. 20(1)
University of Electronic Science and Technology of China (CN), Emory University (US), Wuhan University (CN), Renmin Hospital of Wuhan University (CN), Shenzhen University Health Science Center (CN), Shenzhen Institutes of Advanced Technology (CN), Air Force Medical University (CN)
Research Fund for Young Star of Science and Technology in Shaanxi Province, National Natural Science Foundation of China, Young Talent Support Program of Shaanxi Province University, Shenzhen Research and Development Program, Postdoctoral Research Foundation of China, National Postdoctoral Program for Innovative Talents, Shaanxi Key Science and Technology Innovation Team Project, Basic and Applied Basic Research Foundation of Guangdong Province
Good health and well-being
Openalex Percentile: Top 22%
Alzheimer's disease research and treatments
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition — Jie Xiang, Xi Ye, et al. · Molecular Neurodegeneration (2025) | TGRS Research Map | TGRS